Peter Atadja
University of Health and Allied Sciences(GH)
Publications by Year
Research Areas
Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors, Epigenetics and DNA Methylation, Cancer-related gene regulation, Ubiquitin and proteasome pathways
Most-Cited Works
- → High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response(2015)1,424 cited
- → Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90(2005)749 cited
- → Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family(2002)719 cited
- → Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation(2012)543 cited
- → Epigenetics in cancer: Targeting chromatin modifications(2009)488 cited
- → The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance(2008)449 cited
- → Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges(2009)414 cited
- → Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells(2009)357 cited
- → Aggresome induction by proteasome inhibitor bortezomib and α-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells(2006)340 cited
- → Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3(2004)322 cited